FDA approved a pricey rare disease drug in September despite findings by its data reviewers that the treatment, while safe, ...
In this video, Ahmad Anouti, MD, a pediatric resident at UT Southwestern Medical Center, discusses the importance of being aware of autoimmune biliary diseases to ensure patients get the “appropriate” ...
The U.S. FDA approved a pricey rare disease drug in September despite findings by its data reviewers that the treatment, ...
Allure on MSN
I Thought It Was Acne. Turns Out, It Was Lupus.
But it’s an important detail, along with the fact that I’ve been a beauty journalist for nearly seven years—which means I know my skin, and I know when something is off. So when a spot arrived in the ...
Abcuro, Inc., a late-stage clinical biotechnology company developing potential first-in-class immunotherapies for the benefit of people living with debilitating and progressive rare autoimmune ...
Researchers at the University Hospital Bonn (UKB) and the University of Bonn have discovered how a small, naturally occurring ...
rare lung disease Lack of staff forced Erie nursing home residents to lie in urine, wait weeks for showers There isn't a cure ...
Brian Dawson had just landed his dream job as Pennsylvania’s acting state librarian in 2015 when he came down with a cold. He tried to power through the sickness. But after a couple of weeks, he still ...
Background: Dedifferentiated liposarcoma (DDLPS) is a rare and aggressive malignant tumor, particularly when occurring in the retroperitoneum. Paraneoplastic pemphigus (PNP) is an uncommon autoimmune ...
Division of Hepatology, Department of Medicine, Faculty of Health Sciences, University of Cape Town, 7935 Cape Town, South Africa Sub-Saharan Africa has the highest cirrhosis-related age-standardised ...
Oct 14 (Reuters) - BioCryst Pharmaceuticals (BCRX.O), opens new tab said on Tuesday it would buy Astria Therapeutics (ATXS.O), opens new tab in a cash-and-stock deal valued at about $700 million, ...
Just a few months after surfacing at Orca Bio following his early 2025 departure from Legend Biotech, Steve Gavel has taken on the chief commercial officer role at yet another cell therapy biotech.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback